LFST
LifeStance Health Group, Inc. NASDAQ$7.27
Mkt Cap $2.8B
52w Low $3.74
81.1% of range
52w High $8.09
50d MA $6.78
200d MA $6.12
P/E (TTM)
251.0x
EV/EBITDA
33.8x
P/B
1.9x
Debt/Equity
0.1x
ROE
0.6%
P/FCF
24.7x
RSI (14)
—
ATR (14)
—
Beta
1.13
50d MA
$6.78
200d MA
$6.12
Avg Volume
2.2M
About
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar diso…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 25, 2026 | AMC | -0.00 | 0.03 | +3287.2% | 7.41 | -5.8% | -6.1% | -2.3% | -3.6% | -1.9% | -1.1% | -14.7% | — |
| Nov 6, 2025 | AMC | -0.01 | 0.00 | +128.0% | 6.25 | +1.9% | +0.6% | +2.9% | +3.5% | +3.0% | +1.0% | +2.6% | — |
| Aug 7, 2025 | AMC | -0.03 | -0.01 | +66.7% | 3.86 | +1.8% | +13.2% | +18.4% | +20.7% | +33.9% | +44.6% | +45.3% | — |
| May 7, 2025 | AMC | -0.04 | 0.00 | +104.5% | 5.51 | +0.9% | +5.4% | +4.0% | +6.2% | +6.5% | +4.2% | +6.0% | — |
| Feb 27, 2025 | AMC | -0.04 | -0.02 | +50.0% | 7.74 | +1.2% | +0.6% | +2.2% | +3.6% | +5.4% | +1.8% | -14.0% | — |
| Nov 7, 2024 | AMC | -0.07 | -0.02 | +71.4% | 7.68 | +0.4% | -4.2% | -3.8% | -3.6% | -6.0% | -5.9% | -3.3% | — |
| Aug 8, 2024 | AMC | -0.07 | -0.06 | +14.3% | 5.93 | -2.9% | -5.6% | -7.3% | -1.5% | -4.2% | -1.5% | +17.5% | — |
| May 9, 2024 | AMC | -0.09 | -0.06 | +33.3% | 7.12 | +0.8% | -3.7% | +0.7% | +3.8% | +5.2% | +3.5% | -24.9% | — |
| Feb 28, 2024 | AMC | -0.09 | -0.12 | -33.3% | 8.71 | +1.4% | -4.1% | -10.6% | -10.9% | -15.3% | -16.9% | -28.8% | — |
| Nov 8, 2023 | AMC | -0.07 | -0.17 | -142.9% | 5.82 | +0.7% | -3.4% | -3.6% | -2.9% | +6.7% | +5.2% | +14.9% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 6 | Barclays | Maintains | Overweight → Overweight | — | $6.95 | $7.00 | +0.7% | -0.3% | -0.6% | -3.2% | -4.5% | -8.9% |
| Feb 26 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $7.41 | $6.98 | -5.8% | -6.1% | -2.3% | -3.6% | -1.9% | -1.1% |
| Feb 26 | Canaccord Genuity | Maintains | Buy → Buy | — | $7.41 | $6.98 | -5.8% | -6.1% | -2.3% | -3.6% | -1.9% | -1.1% |
| Feb 26 | UBS | Maintains | Buy → Buy | — | $7.41 | $6.98 | -5.8% | -6.1% | -2.3% | -3.6% | -1.9% | -1.1% |
| Feb 2 | BTIG | Maintains | Buy → Buy | — | $7.07 | $7.17 | +1.4% | +1.6% | +0.6% | -2.0% | -7.5% | -3.4% |
| Dec 12 | BTIG | Maintains | Buy → Buy | — | $6.76 | $6.83 | +1.0% | +2.2% | +2.4% | +1.8% | +2.2% | +2.7% |
| Nov 7 | UBS | Maintains | Buy → Buy | — | $6.25 | $6.37 | +1.9% | +0.6% | +2.9% | +3.5% | +3.0% | +1.0% |
| Nov 6 | BTIG | Maintains | Buy → Buy | — | $4.81 | $5.34 | +11.0% | +29.9% | +30.8% | +33.7% | +34.5% | +33.9% |
| Aug 8 | UBS | Maintains | Buy → Buy | — | $3.86 | $3.93 | +1.8% | +13.2% | +18.4% | +20.7% | +33.9% | +44.6% |
| May 27 | UBS | Upgrade | Neutral → Buy | — | $5.49 | $6.10 | +11.1% | +10.4% | +10.0% | +7.7% | +8.2% | +7.1% |
Recent Filings
8-K
Unknown — 8-K Filing
LFST awarded $1.5M in equity grants to an executive, indicating confidence in leadership stability while potentially diluting existing shareholders' ownership percentages.
Mar 11
8-K
LifeStance Health Group, Inc. -- 8-K Filing
LifeStance Health Group obtained legal counsel opinion from Ropes Gray LLP regarding an unspecified transaction, likely involving securities issuance or corporate action compliance.
Mar 2
8-K · 5.02
!!! Very High
LifeStance Health Group, Inc. -- 8-K 5.02: Executive Change
Kenneth Burdick's transition from Executive Chairman to non-executive Chairman at LifeStance Health indicates a planned leadership restructuring without operational disagreement, potentially signaling management confidence and continuity.
Feb 25
Data updated apr 25, 2026 6:56pm
· Source: massive.com